The reported mortality rates in patients with cirrhosis undergoing various non-transplant surgical procedures range from 8.3% to 25%. This wide range of mortality rates is related to severity of liver disease, type of surgery, demographics of patient population, expertise of the surgical, anesthesia and intensive care unit team and finally, reporting bias. In this article, we will review the pathophysiology, morbidity and mortality associated with non-hepatic surgery in patients with cirrhosis, and then recommend an algorithm for risk assessment and evidence based mnaagement strategy to optimize post-surgical outcomes.
- Model for end-stage liver disease
- Non-transplant surgery
- Pre-operative risk assessment
- Risk stratification
ASJC Scopus subject areas